期刊文献+

坎地沙坦在炎症过程中抑制氧化应激反应机制的研究 被引量:6

The mechanism of anti-inflammation effects by candesartan during inflammation
下载PDF
导出
摘要 目的探讨坎地沙坦(Cand esartan,CAN)是否具有不依赖血管紧张素1型受体(anti-inflammation viaindependent,AT1R)的抗炎作用及其可能的机制。方法以人肾小管上皮细胞为研究对象,观察CAN对肿瘤坏死因子(TNF-α)诱导炎症趋化因子的影响及CAN对TNF-α所诱导ROS的作用。采用RT-PCR方法测定相关分子mRNA表达,Western blotting和ELISA方法测定相关分子蛋白含量。结果 CAN能有效抑制TNF-α诱导炎症趋化因子MCP-1、RANTES mRNA和蛋白表达,且能抑制TNF-α诱导的NF-αB磷酸化。CAN还具有类是抗氧化应激物N乙酰半胱氨酸(NCA)的作用,抑制TNF-α诱导的ROS产生。结论 CAN能抑制TNF-α诱导肾小管上皮细胞发生炎症反应,其机制与CAN的直接抗氧化作用有关。 Objective To study the role of Candesartan (CAN) in anti-inflammation via independent of AT1R pathway and its mechanism. Methods Renal tubular epithelial cells were stimulated by TNF-α. The effects of CAN on inflammatory chemokines and ROS synthesis in the cells induced by TNF-α were observed. The expression level of mRNA was detected by RT-PCR, and the levels of proteins were detected by Western blotting and ELISA. Results CAN suppressed mRNA and protein expressions of pro-inflammatory chemokines MCP-1 and RANTES in human proximal epithelial cells induced by TNF-α with a dose dependent fashion. CAN also inhibited TNF-α-induced NF-KB phosphorylation in the cells. CAN likes N-acetyl cysteine (NAC), a reactive oxygen species (ROS) scavenger, blocked TNF-α and H202-induced ROS generation. Conclusion CAN can suppress infl+ ammatory reponsiveness in the cell induced by TNF-α. The mechanism of the effect maybe associate with its direct anti-ROS generation.
出处 《同济大学学报(医学版)》 CAS 2010年第3期59-63,共5页 Journal of Tongji University(Medical Science)
基金 国家自然科学基金资助项目(30871181) 上海市浦江人才计划(09PJ1408600) 上海市浦东新区科技发展基金创新资金(PKJ2008-Y11)
关键词 血管紧张素Ⅱl型受体 坎地沙坦 肿瘤坏死因子 趋化因子 活性氧 angiotensin Ⅱ type 1 receptor Candesartan TNF-α chemokines reactive oxygenspecies (ROS)
  • 相关文献

参考文献9

  • 1Schulz R,Heusch G.Angiotensin Ⅱ type 1 receptores in cerebral ischaemiareperfusion:initiation of inflammation[J].J Hypertens Suppl,2006,24:S123-S129.
  • 2Manabe S,Okura T,Watanabe S,et al.Effects of angiotensin Ⅱ receptor blockade with valsartan on proinflammatory cytokines in patients with essential hypertension[J].J Cardiovasc Pharmacol,2005,46:735-739.
  • 3Koh KK,Quon MJ,Han SH,et al.Anti-inflammatory and metabolic effects of candesartan in hypertensive patients[J].Int J Cardiol,2006,108:96-100.
  • 4Yu C,Gong R,Rifai A,et al.Long-term,high-dosage candesartan suppresses inflammation and injury in chronic kidney disease:nonhemodynamic renal protection[J].J Am Soc Nephrol,2007,18:750-759.
  • 5Yoshida T,Yamagishi S,Nakamura K.Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation[J].Diabetologia,2006,49:3094-3099.
  • 6Kondo S,Shimizu M,Urushihara M,et al.Addition of the antioxidant probucol to angiotensin Ⅱ type Ⅰ receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat[J].J Am Soc Nephrol,2006,17:783-794.
  • 7Ping D,Jones PL,Boss JM.TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the MCP-1/JE gene[J].Immunity,1996,4:455-469.
  • 8Touyz RM.Reactive oxygen species as mediators of calcium signaling by angiotensin Ⅱ:implications in vascular physiology and pathophysiology[J].Antioxid Redox Signal,2005,7:1302-1314.
  • 9Ohtsu H,Frank GD,Utsunomiya H,et al.Redox-dependent protein kinase regulation by angiotensin Ⅱ:mechanistic insights and its pathophysiology[J].Antioxid Redox Signal,2005,7:1315-1326.

同被引文献67

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部